.svg){kind=small}
Discover opportunities months before the RFP drops
Learn more →Discover opportunities months before the RFP drops
Learn more →Key metrics and characteristics
The city where this buyer is located.
Postal code for this buyer's location.
How likely this buyer is to spend on new technology based on operating budget trends.
How likely this buyer is to adopt new AI technologies.
How often this buyer champions startups and early adoption.
Includes fiscal year calendars, procurement complexity scores, and strategic insights.
Active opportunities open for bidding
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense
Handheld chemical analyzer capable of rapid analytical measurement and non-destructive analysis spectrometry
Posted Date
Oct 28, 2025
Due Date
Nov 21, 2025
Release: Oct 28, 2025
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense
Close: Nov 21, 2025
Handheld chemical analyzer capable of rapid analytical measurement and non-destructive analysis spectrometry
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense
Innovation in biologics manufacturing: Biologics (e.g., antibody) compatible cell free production capability that can support pre-clinical testing and potentially produce 5-10k dose lots of GMP drug substance. Innovations in biologics manufacturing process control (e.g., digital twins). Technologies to reduce biologics drug substance/product release time and/or enable real-time release.
Posted Date
Oct 28, 2025
Due Date
Dec 22, 2025
Release: Oct 28, 2025
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense
Close: Dec 22, 2025
Innovation in biologics manufacturing: Biologics (e.g., antibody) compatible cell free production capability that can support pre-clinical testing and potentially produce 5-10k dose lots of GMP drug substance. Innovations in biologics manufacturing process control (e.g., digital twins). Technologies to reduce biologics drug substance/product release time and/or enable real-time release.
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense
For end-to-end untargeted genomic sequencing workflows appropriate for military use. To survey current industry capabilities in the engineering, testing, and manufacturing of solutions capable of the following: Genomic Sequencing Workflows: End-to-end, untargeted genomic sequencing workflows appropriate for military users with varying levels of technical expertise. Automation of process steps is highly desirable. Workflows must accommodate both environmental and clinical sample matrices. Field-Deployable Bioinformatics Tools: Bioinformatics tools optimized for field use, capable of detecting indicators of genetic engineering and identifying potential biological threats regardless of taxonomic classification. Test & Evaluation (T&E) Infrastructure: Technologies and infrastructure necessary for government-led T&E of untargeted sequencing approaches. Protein Toxin Sequencing: Capabilities for protein toxin sequencing, including both mobile laboratory-based systems and field-deployable platforms.
Posted Date
Oct 28, 2025
Due Date
Dec 19, 2025
Release: Oct 28, 2025
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense
Close: Dec 19, 2025
For end-to-end untargeted genomic sequencing workflows appropriate for military use. To survey current industry capabilities in the engineering, testing, and manufacturing of solutions capable of the following: Genomic Sequencing Workflows: End-to-end, untargeted genomic sequencing workflows appropriate for military users with varying levels of technical expertise. Automation of process steps is highly desirable. Workflows must accommodate both environmental and clinical sample matrices. Field-Deployable Bioinformatics Tools: Bioinformatics tools optimized for field use, capable of detecting indicators of genetic engineering and identifying potential biological threats regardless of taxonomic classification. Test & Evaluation (T&E) Infrastructure: Technologies and infrastructure necessary for government-led T&E of untargeted sequencing approaches. Protein Toxin Sequencing: Capabilities for protein toxin sequencing, including both mobile laboratory-based systems and field-deployable platforms.
Get alerted before the bid drops, know which RFPs to pursue, and generate compliant drafts with AI.
Track Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense's board meetings, strategic plans, and budget discussions. Identify opportunities 6-12 months before competitors see the RFP.
Keep your public sector contacts fresh and actionable. No more stale data.
Premium
Win more deals with deep buyer insights
Premium
Access the largest public sector contact database
.avif&w=256&q=75){kind=small}
.avif&w=256&q=75){kind=small}
.avif&w=256&q=75){kind=small}
.avif&w=256&q=75){kind=small}
.avif&w=256&q=75){kind=small}
.avif&w=256&q=75){kind=small}
.avif&w=256&q=75){kind=small}